Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Czechia Denmark France Germany Italy +2
  • Study on Lithium Sulphate to Prevent Cognitive Impairment in Children After Brain Tumor Radiotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Sweden
  • Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

    Recruiting

    2 1 1 1
    Denmark Lithuania The Netherlands Norway Spain Sweden
  • Study on the Safety and Effectiveness of TransCon CNP for Children and Adolescents with Achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    Austria Denmark Finland France Germany Ireland +4
  • Study on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    Austria Bulgaria Czechia Greece Hungary Italy +3
  • Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

    Recruiting

    3 1 1 1
    Belgium Czechia France Germany Greece Ireland +4
  • Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland Norway Sweden
  • Study on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +6
  • Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

    Recruiting

    3 1
    Investigated Drugs:
    France Germany Poland Romania Spain
  • Study on Long-Term Safety and Effectiveness of Vanzacaftor, Tezacaftor, and Deutivacaftor for Cystic Fibrosis in Patients Aged 1 Year and Older

    Recruiting

    3 1 1 1
    Belgium France Germany The Netherlands Sweden